Pantherna Therapeutics
PrivateLast Round
Follow-on Offering
Jan 11, 2022
Total Funding Raised
$11.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pantherna Therapeutics operates in Healthcare & Life Sciences and is based in Hennigsdorf. Its latest recorded funding round was a Follow-on Offering round in January 2022.
Pantherna Therapeutics is a biotechnology company developing first-in-class mRNA therapeutics for vascular diseases using its proprietary nanoparticle delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pantherna Therapeutics Comparables
Compare Pantherna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ethris | 86% | |
| eTheRNA | 85% | |
| SML BIOPHARM | 82% |
For institutional investors. Book with your work email.
Pantherna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 11, 2022 | ||||
| Grant | May 28, 2021 | ||||
| Seed | Jul 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pantherna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Fund | Seed |
| Brandenburg Kapital | Grant, Seed |
| European Union | Grant |
| High-Tech Gründerfonds | Seed, Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 421% MoM.
- Jun 17, 2026
Monthly visitors grew 196% MoM, reaching 160.
For institutional investors. Book with your work email.
Pantherna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pantherna Therapeutics's valuation, stock price, and market status.
Is Pantherna Therapeutics a public or private company?
Pantherna Therapeutics is a private company.
What is the current stock price of Pantherna Therapeutics?
Pantherna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pantherna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pantherna Therapeutics worth (valuation)?
Valuation information for Pantherna Therapeutics is not publicly available.
Can I buy Pantherna Therapeutics stock?
Pantherna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pantherna Therapeutics's last funding round?
Pantherna Therapeutics's most recent funding round was Follow-on Offering on January 11, 2022.
Who are the main investors in Pantherna Therapeutics?
Key investors in Pantherna Therapeutics include High-Tech Gründerfonds.
Will Pantherna Therapeutics IPO soon?
No public IPO plans have been announced for Pantherna Therapeutics.
How can I track Pantherna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pantherna Therapeutics's shares on secondary markets.